Prosight Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $1.5M | Sell |
|
|||||
2020
Q3 | $11.2M | Buy |
|
|||||
2020
Q2 | $12.8M | Buy |
|
|||||
2020
Q1 | $10.8M | Buy |
|
|||||
2019
Q4 | $12.9M | Buy |
|
|||||
2019
Q3 | $5.03M | Sell |
|
|||||
2019
Q2 | $11.8M | Sell |
|
|||||
2019
Q1 | $15M | Sell |
|
|||||
2018
Q4 | $14.2M | Buy |
|
|||||
2018
Q3 | $6.55M | Sell |
|
|||||
2018
Q2 | $2.91M | Sell |
|
|||||
2018
Q1 | $6.11M | Buy |
|
|||||
2017
Q4 | $4.9M | Buy |
|